Xiaobin Ma
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
-
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 9
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Huafeng Kang (17 shared papers)Bing Du (2 shared papers)Min Qian (2 shared papers)Shuai Lin (6 shared papers)Ruimei Li (1 shared paper)Binghe Tan (1 shared paper)Zhi Zhang (1 shared paper)Mingyao Liu (1 shared paper)
- Journals
- Advanced Science (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Breast Cancer (1 paper)Journal of Controlled Release (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaobin Ma
27 papers receiving 428 citations
Peers
Comparison fields: 5 of 67
- Physiology 65
- Cancer Research 50
- Biomaterials 42
- Infectious Diseases 37
- Oncology 44
Countries citing papers authored by Xiaobin Ma
This map shows the geographic impact of Xiaobin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Ma more than expected).
Fields of papers citing papers by Xiaobin Ma
This network shows the impact of papers produced by Xiaobin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Ma. The network helps show where Xiaobin Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 61 | |
| 2 | 2016 | 51 | |
| 3 | 2019 | 39 | |
| 4 | 2016 | 38 | |
| 5 | 2022 | 29 | |
| 6 | 2021 | 19 | |
| 7 | 2022 | 18 | |
| 8 | 2019 | 16 | |
| 9 | 2022 | 16 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 15 | |
| 12 | 2015 | 12 | |
| 13 | 2023 | 12 | |
| 14 | 2025 | 12 | |
| 15 | 2023 | 10 | |
| 16 | 2017 | 9 | |
| 17 | The role of ATP8A1 in non-small cell lung cancer. | 2017 | 9 |
| 18 | 2024 | 9 | |
| 19 | 2025 | 9 | |
| 20 | 2016 | 8 |
About Xiaobin Ma
Xiaobin Ma is a scholar working on Cancer Research, Biomaterials, Oncology, Physiology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 432 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Nanoparticle-Based Drug Delivery (5 papers), Cancer Immunotherapy and Biomarkers (2 papers), Nanoplatforms for cancer theranostics (2 papers), Adenosine and Purinergic Signaling (2 papers), Ferroptosis and cancer prognosis (2 papers), Lung Cancer Research Studies (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Physiology (65 citations), Cancer Research (50 citations), Biomaterials (42 citations), Infectious Diseases (37 citations) and Oncology (44 citations). Xiaobin Ma has collaborated with scholars based in China and United States. Frequent co-authors include Huafeng Kang, Bing Du, Min Qian, Shuai Lin, Ruimei Li, Binghe Tan, Zhi Zhang, Mingyao Liu, Chunyan Zhang and Na Zhang. Their work appears in journals such as Advanced Science, Journal of Cancer Research and Clinical Oncology, Breast Cancer, Journal of Controlled Release and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.